Aytu BioPharma Enters Material Definitive Agreement

Ticker: AYTU · Form: 8-K · Filed: Jun 23, 2025 · CIK: 1385818

Aytu Biopharma, Inc 8-K Filing Summary
FieldDetail
CompanyAytu Biopharma, Inc (AYTU)
Form Type8-K
Filed DateJun 23, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: material-definitive-agreement, financial-obligation

TL;DR

Aytu BioPharma just signed a big deal, creating a new financial obligation.

AI Summary

On June 20, 2025, AYTU BIOPHARMA, INC. entered into a material definitive agreement, creating a direct financial obligation. The company, formerly known as AYTU BIOSCIENCE, INC., is involved in the pharmaceutical preparations industry.

Why It Matters

This filing indicates a significant new financial commitment or obligation for Aytu BioPharma, which could impact its financial standing and future operations.

Risk Assessment

Risk Level: medium — Entering into material definitive agreements and creating financial obligations can introduce financial risks and operational changes that warrant careful monitoring.

Key Players & Entities

  • AYTU BIOPHARMA, INC. (company) — Registrant
  • AYTU BIOSCIENCE, INC. (company) — Former company name
  • Rosewind CORP (company) — Former company name
  • June 20, 2025 (date) — Date of earliest event reported
  • 20250623 (date) — Filing date

FAQ

What type of material definitive agreement did AYTU BIOPHARMA, INC. enter into?

The filing indicates the entry into a material definitive agreement and the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, but the specific details of the agreement are not provided in this excerpt.

When was the earliest event reported in this 8-K filing?

The earliest event reported is dated June 20, 2025.

What is AYTU BIOPHARMA, INC.'s Standard Industrial Classification (SIC) code?

AYTU BIOPHARMA, INC.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.

What were AYTU BIOPHARMA, INC.'s former company names?

AYTU BIOPHARMA, INC. was formerly known as AYTU BIOSCIENCE, INC. and prior to that, Rosewind CORP.

What is the business address of AYTU BIOPHARMA, INC.?

The business address is 7900 E. UNION AVENUE, SUITE 920, DENVER, CO 80237.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 23, 2025 regarding AYTU BIOPHARMA, INC (AYTU).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.